We are live on ! Find out more
PAMU

Pictet Asset Management (UK) Portfolio holdings

AUM $91.8B
1-Year Est. Return 47.77%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+47.77%
3 Year Est. Return
+102.96%
5 Year Est. Return
+189.45%
10 Year Est. Return
AUM
$91.8B
AUM Growth
+$8.58B
Cap. Flow
+$2.33B
Cap. Flow %
2.53%
Top 10 Hldgs %
12.39%
Holding
1,892
New
100
Increased
613
Reduced
867
Closed
139

Sector Composition

Rank Sector Weight
1 Technology 28.89%
2 Healthcare 15.52%
3 Industrials 13.05%
4 Consumer Discretionary 9.92%
5 Utilities 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOPE icon
476
Grand Canyon Education
LOPE
$3.71B
$25.7M 0.03%
285,132
+23,995
+9% +$2.37M
STT icon
477
State Street
STT
$50.9B
$25.5M 0.03%
309,898
-21,882
-7% -$1.85M
SBAC icon
478
SBA Communications
SBAC
$18.4B
$25.2M 0.03%
79,142
+25,746
+48% +$7.72M
BALL icon
479
Ball Corp
BALL
$17B
$25.2M 0.03%
311,050
+152,064
+96% +$13.2M
OCDX
480
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
$25.2M 0.03%
1,175,237
+14,175
+1% +$288K
BEAM icon
481
Beam Therapeutics
BEAM
$2.58B
$25M 0.03%
194,316
+2,159
+1% +$172K
YMM icon
482
Full Truck Alliance
YMM
$9.56B
$24.9M 0.03%
+1,222,841
New +$24M
F icon
483
Ford
F
$57.3B
$24.6M 0.03%
1,652,368
-81,155
-5% -$1.08M
BAX icon
484
Baxter International
BAX
$11.6B
$24.4M 0.03%
303,433
+79,798
+36% +$6.69M
VEEV icon
485
Veeva Systems
VEEV
$30.3B
$24.2M 0.03%
77,953
+4,716
+6% +$1.31M
NDAQ icon
486
Nasdaq
NDAQ
$51.5B
$24.2M 0.03%
412,608
-27,585
-6% -$1.52M
CPNG icon
487
Coupang
CPNG
$27.8B
$23.8M 0.03%
569,486
+15,521
+3% +$636K
ROKU icon
488
Roku
ROKU
$21.1B
$23.7M 0.03%
51,622
+272
+0.5% +$96.2K
CDW icon
489
CDW
CDW
$17.1B
$23.6M 0.03%
135,396
-1,271
-0.9% -$219K
LH icon
490
Labcorp
LH
$24.3B
$23.5M 0.03%
99,296
+16,083
+19% +$3.66M
ANNX icon
491
Annexon
ANNX
$855M
$23.5M 0.03%
1,042,731
+32,675
+3% +$724K
UTHR icon
492
United Therapeutics
UTHR
$26.3B
$23.4M 0.03%
130,294
-91,063
-41% -$17.3M
MRSN
493
DELISTED
Mersana Therapeutics
MRSN
$23.3M 0.03%
68,486
+330
+0.5% +$125K
TRIL
494
DELISTED
Trillium Therapeutics Inc.
TRIL
$23.2M 0.03%
2,388,417
+1,362,153
+133% +$12.8M
ALXO icon
495
ALX Oncology
ALXO
$273M
$23.1M 0.03%
421,932
+2,039
+0.5% +$122K
MFC icon
496
Manulife Financial
MFC
$72.6B
$23M 0.03%
1,168,741
-51,726
-4% -$1.08M
ARCE
497
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$23M 0.03%
749,279
+275,013
+58% +$7.84M
OXY icon
498
Occidental Petroleum
OXY
$57B
$22.4M 0.02%
717,591
+327,951
+84% +$8.8M
AVB icon
499
AvalonBay Communities
AVB
$27.1B
$22.4M 0.02%
107,440
+27,267
+34% +$5.45M
KKR icon
500
KKR & Co
KKR
$89.2B
$22.4M 0.02%
377,677
+178,931
+90% +$9.93M

Similar funds

Pictet Asset Management (UK)'s Q2 2021 Portfolio in Review

As of Q2 2021, Pictet Asset Management (UK) held 1,892 positions worth $91.8B, up 10% from $83.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Pictet Asset Management (UK)'s Q2 2021 filing shows 100 new, 613 increased, 867 reduced and 139 closed positions. Its largest new stake was Oatly Group: 140,026 shares worth $68.5M. The largest sale was Alibaba, an estimated $550M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.

  • Pictet Asset Management (UK)'s largest Q2 2021 buy was Oatly Group: 140,026 shares worth $68.5M.
  • Pictet Asset Management (UK) added most to Equinix in Q2 2021, an estimated $221M increase.
  • Pictet Asset Management (UK)'s biggest Q2 2021 reduction was Alibaba, cutting an estimated $550M.
  • Pictet Asset Management (UK) fully exited ChemoCentryx, Inc. in Q2 2021, selling an estimated $62.6M.
  • Pictet Asset Management (UK)'s ten largest holdings make up 12% of its $91.8B portfolio in Q2 2021.
  • Pictet Asset Management (UK) opened 100 new positions and closed 139 in Q2 2021.
  • Pictet Asset Management (UK)'s portfolio value rose 10% quarter-over-quarter to $91.8B.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.